Latest ExpreS2ion Biotechnologies News & Updates

See the latest news and media coverage for ExpreS2ion. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
ExpreS2ion Biotechnologies (ExpreS2ion)

Clinical-stage immunotherapy biotechnology company

expres2ionbio.com
Headquarters
Horsholm, Denmark
Founded year
2010
Company type
Public company
Number of employees
20–50
Industry
Biotechnology & Medical Research

Last updated

Latest news about ExpreS2ion Biotechnologies (ExpreS2ion)

In short: ExpreS2ion reported positive Phase I data for its breast cancer vaccine and raised significant capital via rights issues and warrants.

Company announcements

ExpreS2ion

ExpreS2ion secures SEK 69.3M financing

ExpreS2ion obtains warrants guarantee and enters a SEK 50M put option agreement with Alumni Capital to fund Phase I trials and maintain financial flexibility.

ExpreS2ion

ExpreS2ion announces a rights issue in 2020

The offering aims to raise capital for development and expansion activities.

Unlock all announcements with a

Media coverage

The Wall Street Journal

ExpreS2ion Biotech Holding AB

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...

Investing.com

EXPRS2 Share News Today

ExpreS2ion Biotechnologies reported a 36% year-over-year increase in total income for the third quarter of 2025. The company also...

Unlock all articles with a

Never miss news about ExpreS2ion

Track ExpreS2ion and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

ExpreS2ion competitors & trending companies

Browse news for competitors to ExpreS2ion and other trending companies.